ECSP088293A - Inhibidores de gamma secretasa, de sulfonamido n-cíclico puenteado - Google Patents

Inhibidores de gamma secretasa, de sulfonamido n-cíclico puenteado

Info

Publication number
ECSP088293A
ECSP088293A EC2008008293A ECSP088293A ECSP088293A EC SP088293 A ECSP088293 A EC SP088293A EC 2008008293 A EC2008008293 A EC 2008008293A EC SP088293 A ECSP088293 A EC SP088293A EC SP088293 A ECSP088293 A EC SP088293A
Authority
EC
Ecuador
Prior art keywords
formula
compounds
secretasa
sulfonamide
gamma
Prior art date
Application number
EC2008008293A
Other languages
English (en)
Inventor
Andrei Konradi
Christopher M Semko
Matthew N Mattson
Xiacong Michael Ye
Original Assignee
Elan Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elan Pharm Inc filed Critical Elan Pharm Inc
Publication of ECSP088293A publication Critical patent/ECSP088293A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/14—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing 9-azabicyclo [3.3.1] nonane ring systems, e.g. granatane, 2-aza-adamantane; Cyclic acetals thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

La invención provee compuestos de sulfonamido N-cíclicos y sales de la Fórmula: , donde A se define conforme a lo descripto en la memoria descriptiva, y R1 y R2 se combinan para formar un sistema de anillo [3.3.1] o [3.2.1], donde el nitrógeno está unido a los dos carbonos puenteados, y los sistemas de anillo [3.3.1] o [3.2.1] están opcionalmente fusionados con un anillo heteroarilo o heterocicloalquilo. Los compuestos de Fórmula I son útiles en el tratamiento o la prevención de trastornos cognitivos, tales como la enfermedad de Alzheimer. La invención además contempla composiciones farmacéuticas que comprenden compuestos de Fórmula I; métodos de tratamiento de trastornos cognitivos, tales como la enfermedad de Alzheimer; y los intermediarios útiles para la preparación de los compuestos de Fórmula I.
EC2008008293A 2005-08-19 2008-03-18 Inhibidores de gamma secretasa, de sulfonamido n-cíclico puenteado ECSP088293A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70996105P 2005-08-19 2005-08-19

Publications (1)

Publication Number Publication Date
ECSP088293A true ECSP088293A (es) 2008-04-28

Family

ID=37758487

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2008008293A ECSP088293A (es) 2005-08-19 2008-03-18 Inhibidores de gamma secretasa, de sulfonamido n-cíclico puenteado

Country Status (16)

Country Link
US (4) US20110178119A1 (es)
EP (2) EP1915371A4 (es)
JP (2) JP2009506988A (es)
KR (1) KR20080042135A (es)
CN (2) CN101426860A (es)
AR (1) AR056470A1 (es)
AU (2) AU2006283567A1 (es)
BR (1) BRPI0614944A2 (es)
CA (2) CA2618087A1 (es)
EC (1) ECSP088293A (es)
IL (2) IL189217A0 (es)
MX (1) MX2008002234A (es)
RU (2) RU2422443C2 (es)
TW (1) TW200740806A (es)
WO (2) WO2007024651A2 (es)
ZA (1) ZA200803521B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7923465B2 (en) 2005-06-02 2011-04-12 Glenmark Pharmaceuticals S.A. Cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation
WO2007024651A2 (en) * 2005-08-19 2007-03-01 Elan Pharmaceuticals, Inc. Bridged n-bicyclic sulfonamido inhibitors of gamma secretase
US7732609B2 (en) * 2005-12-01 2010-06-08 Elan Pharmaceuticals, Inc. 5-(arylsulfonyl)-pyrazolopiperidines
CA2687765A1 (en) 2007-05-25 2008-12-04 Elan Pharmaceuticals, Inc. Pyrazolopyrrolidines as inhibitors of gamma secretase
EP2195315B1 (en) * 2007-08-15 2017-01-18 Merck Sharp & Dohme Corp. Substituted bicyclic piperidinyl-and piperazinyl- sulfonamides useful to inhibit 11 -hydroxysteroid dehydrogenase type-1
RU2544856C2 (ru) 2008-01-25 2015-03-20 Сергей Олегович Бачурин НОВЫЕ ПРОИЗВОДНЫЕ 2,3,4,5-ТЕТРАГИДРО-1-ПИРИДО[4,3-b]ИНДОЛА И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
PE20091820A1 (es) * 2008-03-24 2009-12-10 Medivation Technologies Inc Compuestos heterociclicos con uniones puente y metodos para usarlos
AU2009289579A1 (en) * 2008-09-05 2010-03-11 Elan Pharmaceuticals, Inc. N-sulfonamido polycyclic pyrazolyl compounds
BR112012006648A2 (pt) 2009-09-23 2019-09-24 Medivation Neurology Inc composto,método de tratamento de um distúrbio cognitivo, distúrbio psicótico, distúrbio mediado por neurotransmissor ou um distúrbio neuronal, composição farmacêutica e kit
CA2775328A1 (en) 2009-09-23 2011-03-31 Medivation Technologies, Inc. Pyrido[4,3-b]indoles and methods of use
TWI471095B (zh) 2009-12-21 2015-02-01 Nippon Soda Co 環胺化合物及殺蟎劑
AR081721A1 (es) 2010-02-25 2012-10-17 Nippon Soda Co Compuesto de amina ciclica y acaricida
EP2609081A1 (en) 2010-08-23 2013-07-03 Amgen Inc. Sulfonylpiperazine derivatives that interact with glucokinase regulatory protein for the treatment of diabetes
WO2012154261A1 (en) 2011-02-18 2012-11-15 Medivation Technologies, Inc. Compounds and methods of treating diabetes
AU2012290116B2 (en) * 2011-08-02 2016-11-03 Buck Institute For Research On Aging Tropinol esters and related compounds to promote normal processing of APP
EP2690102A1 (en) * 2012-07-24 2014-01-29 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Bicyclic aza-amides for treatment of psychiatric disorders
WO2016187772A1 (zh) * 2015-05-25 2016-12-01 华为技术有限公司 一种光致变色镜头、摄像头及终端设备

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4232158A (en) * 1979-06-04 1980-11-04 Merck & Co., Inc. 10,11-Dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imines
JPH01132585A (ja) * 1987-11-17 1989-05-25 Kyowa Hakko Kogyo Co Ltd Ｄｃ−５２誘導体
US5256656A (en) * 1990-07-31 1993-10-26 Nisshin Flour Milling Co., Ltd. Azabicyclo derivatives
JP3218621B2 (ja) * 1990-10-11 2001-10-15 住友化学工業株式会社 芳香族系化合物、その製造法およびそれを有効成分とする有害生物防除剤
GB9510459D0 (en) * 1995-05-24 1995-07-19 Zeneca Ltd Bicyclic amines
US5795890A (en) * 1995-09-27 1998-08-18 Ono Pharmaceutical Co., Ltd. Sulfonamide derivatives
CZ285571B6 (cs) * 1995-11-02 1999-09-15 Neurosearch A/S Kondenzované tropanové deriváty, způsob jejich výroby, farmaceutické prostředky, které je obsahují a jejich použití k léčení
EP1006113A1 (en) * 1998-12-02 2000-06-07 Pfizer Products Inc. Derivatives of 2-(2-oxo-ethylidene)-imidazolidin-4-one and their use to inhibit abnormal cell growth
AU768720B2 (en) * 1999-04-01 2004-01-08 Pfizer Products Inc. Aminopyrimidines as sorbitol dehydrogenase inhibitors
EP1088819B1 (en) * 1999-09-30 2005-06-15 Pfizer Products Inc. 6-azauracil derivatives as thyroid receptor ligands
EP1118612A1 (en) * 2000-01-21 2001-07-25 Universita Degli Studi di Firenze Piperazine derivatives possesing nootropic activity
MXPA03010255A (es) * 2001-05-10 2005-03-07 Agouron Pharma Ligandos heterobiciclicos de proteinas de union a fk-506.
GB0119152D0 (en) * 2001-08-06 2001-09-26 Merck Sharp & Dohme Therapeutic agents
TW200302717A (en) * 2002-02-06 2003-08-16 Schering Corp Novel gamma secretase inhibitors
HUP0202001A2 (hu) * 2002-06-14 2005-08-29 Sanofi-Aventis DDP-IV gátló hatású azabiciklooktán- és nonánszármazékok
US7368457B2 (en) * 2003-05-13 2008-05-06 Schering Corporation Bridged N-arylsulfonylpiperidines as gamma-secretase inhibitors
WO2006002133A1 (en) * 2004-06-22 2006-01-05 Schering Corporation Cannabinoid receptor ligands
CA2585172C (en) * 2004-10-29 2014-08-12 Kalypsys, Inc. Sulfonyl-substituted bicyclic compounds as modulators of ppar
US7615570B2 (en) * 2004-12-13 2009-11-10 Abbott Laboratories Antagonists to the vanilloid receptor subtype 1 (VR1) and uses thereof
WO2007024651A2 (en) * 2005-08-19 2007-03-01 Elan Pharmaceuticals, Inc. Bridged n-bicyclic sulfonamido inhibitors of gamma secretase

Also Published As

Publication number Publication date
EP1915371A2 (en) 2008-04-30
CN101304997A (zh) 2008-11-12
WO2007022502A2 (en) 2007-02-22
RU2008133306A (ru) 2010-02-20
BRPI0614944A2 (pt) 2011-04-26
WO2007024651A2 (en) 2007-03-01
US7345056B2 (en) 2008-03-18
CN101426860A (zh) 2009-05-06
IL190970A0 (en) 2009-02-11
AU2006283567A1 (en) 2007-03-01
ZA200803521B (en) 2009-12-30
US20080090817A1 (en) 2008-04-17
US7754712B2 (en) 2010-07-13
IL189217A0 (en) 2008-06-05
KR20080042135A (ko) 2008-05-14
AR056470A1 (es) 2007-10-10
RU2008110488A (ru) 2009-09-27
US20110003802A1 (en) 2011-01-06
JP2009504773A (ja) 2009-02-05
WO2007024651A3 (en) 2007-07-12
EP1916985A2 (en) 2008-05-07
EP1916985A4 (en) 2010-06-09
RU2422443C2 (ru) 2011-06-27
CA2632670A1 (en) 2007-02-22
US20110178119A1 (en) 2011-07-21
TW200740806A (en) 2007-11-01
WO2007022502A3 (en) 2007-10-04
JP2009506988A (ja) 2009-02-19
AU2006279312A1 (en) 2007-02-22
EP1915371A4 (en) 2010-09-15
CA2618087A1 (en) 2007-03-01
US20070049612A1 (en) 2007-03-01
MX2008002234A (es) 2008-03-27

Similar Documents

Publication Publication Date Title
ECSP088293A (es) Inhibidores de gamma secretasa, de sulfonamido n-cíclico puenteado
ATE517882T1 (de) Chinolinderivate
EA200870127A1 (ru) Полициклические производные аминокислот и способы их применения
EA201500182A1 (ru) 4-МЕТИЛ-2,3,5,9,9b-ПЕНТААЗАЦИКЛОПЕНТА[a]НАФТАЛИНЫ
EA201001159A1 (ru) Конденсированные гетероциклические производные и их применение
EA201690019A1 (ru) Производное аминотриазина и содержащая его фармацевтическая композиция
UA103272C2 (uk) 2-аміно-5,5-дифтор-5,6-дигідро-4h-оксазини як інгібітори bace1 і/або bace2
EA201500298A1 (ru) Алкоксипиразолы в качестве активаторов растворимой гуанилатциклазы
EA201200176A1 (ru) Производные оксазина и их применение для лечения неврологических нарушений
EA200702339A1 (ru) Замещенные амидные производные в качестве ингибиторов протеинкиназы
EA201390908A1 (ru) Производные бицикло[3.2.1]октиламида и их применение
EA201200952A1 (ru) Производные пиразина и их применение для лечения неврологических нарушений
EA201400358A1 (ru) Замещенные n-[1-циано-2-(фенил)этил]-2-азабицикло[2.2.1]гептан-3-карбоксамидные ингибиторы катепсина с
EA200900152A1 (ru) Ингибиторы пирролотриазинкиназы
CU20090184A7 (es) Compuestos amino-heterocíclicos
EA201001733A1 (ru) Производные тиенопиридона в качестве активаторов амр-активированной протеинкиназы (амрк)
CR20130588A (es) Halogenoalquil-1,3-oxazinas como inhibidores de la bace1 y/o bace 2
UA109916C2 (uk) 2-аміно-4-арилтіазольні сполуки як антагоністи trра1
EA201070169A1 (ru) 2,3-дигидробензо[1,4]диоксин-2-илметиловые производные в качестве альфа2с антагонистов для применения в лечении заболеваний перифирической центральной нервной системы
EA200802007A1 (ru) Соединения, потенцирующие рецептор амра, и применение указанных соединений в медицине
ATE307810T1 (de) Imidazol-2-carbonsäureamid derivate als raf- kinase-inhibitoren
EA200870577A1 (ru) Конденсированные трициклические сульфонамидные ингибиторы гамма-секретазы
BR112012028445A2 (pt) compostos de heteroarila bicíclica como moduladores de gpr119
PA8604201A1 (es) Derivados de 2-amino-piridina utiles para el tratamiento de enfermedades
EA200601212A1 (ru) Ингибиторы фосфодиэстеразы, получение и их терапевтическое применение